Literature DB >> 17826455

Relationships between spasticity, strength, gait, and the GMFM-66 in persons with spastic diplegia cerebral palsy.

Sandy A Ross1, Jack R Engsberg.   

Abstract

OBJECTIVE: To determine the relationships between spasticity, strength, and the functional measures of gait and gross motor function in persons with spastic diplegia cerebral palsy (CP).
DESIGN: Retrospective, cross-sectional study.
SETTING: Hospital clinic. PARTICIPANTS: Ninety-seven participants (49 boys, 48 girls; mean age+/-standard deviation, 9.11+/-4.8 y) with spastic diplegia CP were tested once.
INTERVENTIONS: Not applicable. MAIN OUTCOME MEASURES: A KinCom dynamometer was used to objectively measure spasticity (ankle plantarflexors, knee flexors, hip adductors) and maximum strength (ankle dorsiflexors and plantarflexors, knee flexors and extensors, hip abductors and adductors). A gait analysis was conducted to evaluate linear variables (gait speed, stride length, cadence) and kinematic variables (ankle dorsiflexion, foot progression, knee and hip flexion, pelvic tilt at initial contact and ankle dorsiflexion, knee and hip flexion, pelvic tilt, trunk rotation range of motion) during gait. Gross motor function was measured using the Gross Motor Function Measure (GMFM-66) and separately, the GMFM walking, running & jumping dimension. Multiple linear regression analysis was used to determine the relationships between spasticity, strength, gait, and the GMFM (P<.05).
RESULTS: Spasticity did not account for a substantial amount of explained variance in gait and gross motor function (up to 8% for the GMFM walking, running & jumping dimension). Moderate to high correlations existed between strength and gait linear data and function, accounting for up to 69% of the explained variance (strength and GMFM-66, r2=.69).
CONCLUSIONS: For this cohort of participants with spastic diplegia CP who ambulated with or without an assistive device, strength was highly related to function and explained far more of the variance than spasticity. The results may not be generalized to those with more severe forms of CP.

Entities:  

Mesh:

Year:  2007        PMID: 17826455     DOI: 10.1016/j.apmr.2007.06.011

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  52 in total

1.  Trunk and hip muscle activity in early walkers with and without cerebral palsy--a frequency analysis.

Authors:  Laura A Prosser; Samuel C K Lee; Mary F Barbe; Ann F VanSant; Richard T Lauer
Journal:  J Electromyogr Kinesiol       Date:  2010-05-15       Impact factor: 2.368

2.  How robust is human gait to muscle weakness?

Authors:  Marjolein M van der Krogt; Scott L Delp; Michael H Schwartz
Journal:  Gait Posture       Date:  2012-03-03       Impact factor: 2.840

Review 3.  Neuromuscular electrical stimulation to improve gross motor function in children with cerebral palsy: a meta-analysis.

Authors:  Ana Paula Salazar; Aline Souza Pagnussat; Gabriela Alves Pereira; Gabriela Scopel; Janice Luisa Lukrafka
Journal:  Braz J Phys Ther       Date:  2019-01-23       Impact factor: 3.377

4.  Trunk and hip muscle activation patterns are different during walking in young children with and without cerebral palsy.

Authors:  Laura A Prosser; Samuel C K Lee; Ann F VanSant; Mary F Barbe; Richard T Lauer
Journal:  Phys Ther       Date:  2010-04-29

5.  Plantar flexor voluntary activation capacity, strength and function in cerebral palsy.

Authors:  Shari M O'Brien; Timothy J Carroll; Lee A Barber; Glen A Lichtwark
Journal:  Eur J Appl Physiol       Date:  2021-03-09       Impact factor: 3.078

6.  Influence of age on step activity patterns in children with cerebral palsy and typically developing children.

Authors:  Sandra L Stevens; Elizabeth A Holbrook; Dana K Fuller; Don W Morgan
Journal:  Arch Phys Med Rehabil       Date:  2010-12       Impact factor: 3.966

Review 7.  Complicated Muscle-Bone Interactions in Children with Cerebral Palsy.

Authors:  Christopher M Modlesky; Chuan Zhang
Journal:  Curr Osteoporos Rep       Date:  2020-02       Impact factor: 5.096

8.  Multilevel botulinum toxin type a as a treatment for spasticity in children with cerebral palsy: a retrospective study.

Authors:  Ece Unlu; Alev Cevikol; Burcu Bal; Emel Gonen; Ozlem Celik; Gulşen Kose
Journal:  Clinics (Sao Paulo)       Date:  2010-06       Impact factor: 2.365

9.  Contributing factors analysis for the changes of the gross motor function in children with spastic cerebral palsy after physical therapy.

Authors:  Tae Im Yi; Ju Ryeon Jin; Sung Heon Kim; Kyung Hee Han
Journal:  Ann Rehabil Med       Date:  2013-10-29

10.  The relationship between spasticity in young children (18 months of age) with cerebral palsy and their gross motor function development.

Authors:  Jan Willem Gorter; Olaf Verschuren; Laura van Riel; Marjolijn Ketelaar
Journal:  BMC Musculoskelet Disord       Date:  2009-09-04       Impact factor: 2.362

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.